Sex: U
Vaccine: COVID19
Symptoms: COVID-19, Interchange of vaccine products, SARS-CoV-2 test
Clinical narrative: for primary series and then got booster of Moderna COVID-19 Vaccine; tested positive for COVID-19 after Moderna booster; This spontaneous case was reported by a nurse and describes the occurrence of COVID-19 (tested positive for COVID-19 after Moderna booster) and INTERCHANGE OF VACCINE PRODUCTS (for primary series and then got booster of Moderna COVID-19 Vaccine) in an adult patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 prophylaxis.     Previously administered products included for Product used for unknown indication: ( for primary series) and   (for primary series). Past adverse reactions to the above products included No adverse event with.    In October 2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Jun-2022, the patient experienced COVID-19 (tested positive for COVID-19 after Moderna booster). On an unknown date, the patient experienced INTERCHANGE OF VACCINE PRODUCTS ( for primary series and then got booster of Moderna COVID-19 Vaccine). At the time of the report, COVID-19 (tested positive for COVID-19 after Moderna booster) and INTERCHANGE OF VACCINE PRODUCTS ( for primary series and then got booster of Moderna COVID-19 Vaccine) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 13-Jun-2022, SARS-CoV-2 test: positive (Positive) tested positive for COVID-19 after Moderna booster.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Nurse has 2 patient is in their 30s that had one booster. Concomitant medication was not reported. Treatment medication was not reported.  Company comment: This spontaneous case concerns a patient (age and gender unspecified) with history of interchange of vaccine products, who experienced the unexpected non-serious of Covid-19, after mRNA-1273 vaccine received as 3rd dose. SARS-CoV-2 test was positive. The outcome was reported as unknown. Details of clinical course, further investigation reports and treatment were not provided. Prior to the Moderna dose the patient has received two doses of JANSSEN COVID-19 VACCINE NRVV AD26 (JNJ 78436735)  dates unspecified. The current pandemic situation of Covid-19 remains a confounder. The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report.; Sender's Comments: This spontaneous case concerns a patient (age and gender unspecified) with history of interchange of vaccine products, who experienced the unexpected non-serious of Covid-19, after mRNA-1273 vaccine received as 3rd dose. SARS-CoV-2 test was positive. The outcome was reported as unknown. Details of clinical course, further investigation reports and treatment were not provided. Prior to the Moderna dose the patient has received two doses of JANSSEN COVID-19 VACCINE NRVV AD26 (JNJ 78436735)  dates unspecified. The current pandemic situation of Covid-19 remains a confounder. The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report.